use of α-interferon, amantadin and isoprinosine in subacute sclerosing panencephalitis (sspe): comparing the effectiveness
نویسندگان
چکیده
objective sub acute sclerosing pan encephalitis (sspe), a progressive neurological disorder characterized by inflammation of the brain (encephalitis), is the result of an inappropriate immune response to the measles virus or measles vaccination. sspe usually develops 2 to 10 years after the original viral attack. some of the major signs and symptoms are mental deterioration, jerky movements, and seizures specially myoclonic type, involuntary movements, and/or behavioral changes, difficulty in walking, speech, and loss of cognition, respiratory distress and death. materials and methods during the ten years, from july 1991 to july 2001, we admitted 45 cases of (sspe), at different stages of the disorder. regardless of their stage of disease, for intervention, randomly, we used one of three drugs; amantadin, interferon alfa and isoprinosine, administered to the patients, for between one month to one year. fourteen cases received amantadin, 15 alfa interferon, and 16 were given isoprinosine. results while the results show all three drugs to be relatively effective, isoprinosine showed four times more effectiveness than amantadin and twice as much as interferon. conclusion the results showed isoprinosine to be much more effective than amantadin and alfa interferon in treating the condition.
منابع مشابه
Use of Α-interferon, Amantadin and Isoprinosine in Subacute Sclerosing Panencephalitis (sspe): Comparing the Effectiveness
Email: [email protected] Abstract Objective Sub acute Sclerosing Pan Encephalitis (SSPE), a progressive neurological disorder characterized by inflammation of the brain (encephalitis), is the result of an inappropriate immune response to the measles virus or measles vaccination. SSPE usually develops 2 to 10 years after the original viral attack. Some of the major signs and symptoms are m...
متن کاملSubacute Sclerosing Panencephalitis (SSPE) - due to Lack of Complete Immunization?
The child was admitted in the paediatric department with complaints of fits for one month and altered level of consciousness for two days prior to admission. Mother had also noticed changes in behaviour for one month. He became unusually frightened when he was alone and in a dark room. Fits were not controlled for two days when he came to Abbasi Shaheed hospital and child became drowsy. He was ...
متن کاملSubacute sclerosing panencephalitis (SSPE) associated with congenital measles infection.
A 13-month-old male presented with repetitive episodes of myoclonic jerks of the head and extremities for two months. His past medical history revealed that his non-immunized mother had measles at the time of delivery. Measles antibody titers in serum and cerebrospinal fluid (CSF) were 1/512 (hemagglutinin inhibition [HI]) and 1/128 HI, respectively. Immunofixation electrophoresis of CSF reveal...
متن کامل[Subacute sclerosing panencephalitis].
Subacute sclerosing panencephalitis is a slowly progressive neurodegenerative disorder occurring in childhood and adolescence and is characterised by dementia, ataxia, myoclonias and other neurological focal signs, with an invariably fatal outcome. The author reviews the subject, focussing on epidemiology, clinical features, measles virus behaviour, host immune reactions, measles prophylaxis an...
متن کاملSubacute sclerosing panencephalitis.
Introduction Subacute sclerosing panencephalitis (SSPE) is a rare disease which predominantly affects children of school age. The clinical features include an insidious afebrile onset with behavioural disturbance and progressive dementia sometimes associated with epilepsy. Later akinetic mutism and myoclonic jerks with pyramidal and extrapyramidal signs appear. Finally there is progressive deco...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of child neurologyجلد ۲، شماره ۲، صفحات ۲۷-۳۲
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023